Increasing long-term safety of seasonal grass pollen sublingual immunotherapy: the ECRIT study

Bibliography

• Radulovic S, Wilson D, Calderon M, Durham S. Systematic reviews of sublingual immunotherapy (SLIT). Allergy 2011;11(6):740-52
   Google Scholar
• Canonica GW, Passalacqua G. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients. Allergy 2006;61(Suppl 81):20-3
   PubMedGoogle Scholar
• Bousquet J, Khaltaev N, Cruz AA, Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160
   PubMed Web of Science ®Google Scholar
• Canonica GW, Bousquet J, Casale T, Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy 2009;64(Suppl 91):1-59
   PubMed Web of Science ®Google Scholar
• Olaguibel JM, Alvarez Puebla MJ. Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis. J Investig Allergol Clin Immunol 2005;15(1):9-16
   PubMed Web of Science ®Google Scholar
• Didier A, Malling HJ, Worm M, Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007;120(6):1338-45
   PubMed Web of Science ®Google Scholar
• Wahn U, Tabar A, Kuna P, Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009;123(1):160-6; e3
   PubMed Web of Science ®Google Scholar
• Malling HJ. Comparison of the clinical efficacy and safety of subcutaneous and sublingual immunotherapy: methodological approaches and experimental results. Curr Opin Allergy Clin Immunol 2004;4(6):539-42
   PubMedGoogle Scholar
• Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60(1):4-12
   PubMed Web of Science ®Google Scholar
• Di Rienzo V, Pagani A, Parmiani S, Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 1999;54(10):1110-13
   PubMed Web of Science ®Google Scholar
• Grosclaude M, Bouillot P, Alt R, Safety of various dosage regimens during induction of sublingual immunotherapy. A preliminary study. Int Arch Allergy Immunol 2002;129(3):248-53
   PubMed Web of Science ®Google Scholar
• Rossi RE, Monasterolo G. A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma. Int J Immunopathol Pharmacol 2005;18(2):277-85
   PubMed Web of Science ®Google Scholar
• Vervloet D, Birnbaum J, Laurent P, Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhinoconjunctivitis. A double-blind, placebo-controlled study. Int Arch Allergy Immunol 2007;142(3):239-46
   PubMed Web of Science ®Google Scholar
• Durham SR, Emminger W, Kapp A, Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010;125(1):131-8; e1-7
   PubMed Web of Science ®Google Scholar
• Ott H, Sieber J, Brehler R, Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009;64(9):1394-401
   PubMed Web of Science ®Google Scholar
• GINA (Global Initiative for Asthma). Global strategy for asthma management and prevention. Workshop Report; 2009 December 2008
   Google Scholar
• Joint Task Force on Practice Parameters. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol 2007;120(3 Suppl):S25-85
   PubMed Web of Science ®Google Scholar
• Madonini E, Agostinis F, Barra R, Long-term and preventive effects of sublingual allergen-specific immunotherapy: a retrospective, multicentric study. Int J Immunopathol Pharmacol 2003;16(1):73-9
   PubMed Web of Science ®Google Scholar
• Di Rienzo V, Marcucci F, Puccinelli P, Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003;33(2):206-10
   PubMed Web of Science ®Google Scholar
• Bodtger U, Poulsen LK, Malling HJ. Retrospective assessment of seasonal allergic symptoms: over-rating but useful. Clin Exp Allergy 2003;33(4):496-500
   PubMed Web of Science ®Google Scholar
• CMS Update. Desensitising vaccines. Br Med J (Clin Res Ed) 1986;293:948
   PubMedGoogle Scholar
• Reid MJ, Lockey RF, Turkeltaub PC, Platts-Mills TA. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 1993;92(1 Pt 1):6-15
   PubMed Web of Science ®Google Scholar
• Guerra L, Compalati E, Rogkakou A, Randomized open comparison of the safety of SLIT in a no-updosing and traditional updosing schedule in patients with Parietaria allergy. Allergol Immunopathol (Madr) 2006;34(2):82-3
   PubMedGoogle Scholar
• De Groot H, Bijl A. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet. Allergy 2009;64(6):963-4
   PubMed Web of Science ®Google Scholar
• Penagos M, Compalati E, Tarantini F, Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006;97(2):141-8
   PubMed Web of Science ®Google Scholar
• Penagos M, Passalacqua G, Compalati E, Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008;133(3):599-609
   PubMed Web of Science ®Google Scholar
• Gidaro GB, Marcucci F, Sensi L, The safety of sublingual-swallow immunotherapy: an analysis of published studies. Clin Exp Allergy 2005;35(5):565-71
   PubMed Web of Science ®Google Scholar